 | • レポートコード：GIR-107A11915 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、スティル病治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。スティル病治療の種類別市場規模（コルチコステロイド、トシリズマブ、カナキヌマブ、アナキンラ、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・スティル病治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AB2 Bio Ltd、Novartis AG、F. Hoffmann-La Roche Ltd、Swedish Orphan Biovitrum AB、Jubilant、Hikma Pharmaceuticals PLC、Teva Pharmaceutical Industries Ltd、Viatris、Horizon Therapeutics plc、Sun Pharmaceutical Industries Ltd、Zydus Cadila、Amneal Pharmaceuticals LLC、Dr Reddy's Laboratories Ltd、Fresenius Kabi AG ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：コルチコステロイド、トシリズマブ、カナキヌマブ、アナキンラ、その他 ・用途別分析2016年-2026年：小売薬局、病院薬局、オンライン薬局 ・スティル病治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・スティル病治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・スティル病治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・スティル病治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・スティル病治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Still’s Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Still’s Disease Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Still’s Disease Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Still’s Disease Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Corticosteroids
Tocilizumab
Canakinumab
Anakinra
Others
Market segment by Application, can be divided into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Market segment by players, this report covers
AB2 Bio Ltd
Novartis AG
F. Hoffmann-La Roche Ltd
Swedish Orphan Biovitrum AB
Jubilant
Hikma Pharmaceuticals PLC
Teva Pharmaceutical Industries Ltd
Viatris
Horizon Therapeutics plc
Sun Pharmaceutical Industries Ltd
Zydus Cadila
Amneal Pharmaceuticals LLC
Dr Reddy’s Laboratories Ltd
Fresenius Kabi AG
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Still’s Disease Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Still’s Disease Treatment, with revenue, gross margin and global market share of Still’s Disease Treatment from 2019 to 2021.
Chapter 3, the Still’s Disease Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Still’s Disease Treatment market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Still’s Disease Treatment research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Still’s Disease Treatment
1.2 Classification of Still’s Disease Treatment by Type
1.2.1 Overview: Global Still’s Disease Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Still’s Disease Treatment Revenue Market Share by Type in 2020
1.2.3 Corticosteroids
1.2.4 Tocilizumab
1.2.5 Canakinumab
1.2.6 Anakinra
1.2.7 Others
1.3 Global Still’s Disease Treatment Market by Application
1.3.1 Overview: Global Still’s Disease Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Still’s Disease Treatment Market Size & Forecast
1.5 Global Still’s Disease Treatment Market Size and Forecast by Region
1.5.1 Global Still’s Disease Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Still’s Disease Treatment Market Size by Region, (2016-2021)
1.5.3 North America Still’s Disease Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Still’s Disease Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Still’s Disease Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Still’s Disease Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Still’s Disease Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Still’s Disease Treatment Market Drivers
1.6.2 Still’s Disease Treatment Market Restraints
1.6.3 Still’s Disease Treatment Trends Analysis
2 Company Profiles
2.1 AB2 Bio Ltd
2.1.1 AB2 Bio Ltd Details
2.1.2 AB2 Bio Ltd Major Business
2.1.3 AB2 Bio Ltd Still’s Disease Treatment Product and Solutions
2.1.4 AB2 Bio Ltd Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AB2 Bio Ltd Recent Developments and Future Plans
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Still’s Disease Treatment Product and Solutions
2.2.4 Novartis AG Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis AG Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche Ltd
2.3.1 F. Hoffmann-La Roche Ltd Details
2.3.2 F. Hoffmann-La Roche Ltd Major Business
2.3.3 F. Hoffmann-La Roche Ltd Still’s Disease Treatment Product and Solutions
2.3.4 F. Hoffmann-La Roche Ltd Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.4 Swedish Orphan Biovitrum AB
2.4.1 Swedish Orphan Biovitrum AB Details
2.4.2 Swedish Orphan Biovitrum AB Major Business
2.4.3 Swedish Orphan Biovitrum AB Still’s Disease Treatment Product and Solutions
2.4.4 Swedish Orphan Biovitrum AB Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Swedish Orphan Biovitrum AB Recent Developments and Future Plans
2.5 Jubilant
2.5.1 Jubilant Details
2.5.2 Jubilant Major Business
2.5.3 Jubilant Still’s Disease Treatment Product and Solutions
2.5.4 Jubilant Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Jubilant Recent Developments and Future Plans
2.6 Hikma Pharmaceuticals PLC
2.6.1 Hikma Pharmaceuticals PLC Details
2.6.2 Hikma Pharmaceuticals PLC Major Business
2.6.3 Hikma Pharmaceuticals PLC Still’s Disease Treatment Product and Solutions
2.6.4 Hikma Pharmaceuticals PLC Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Hikma Pharmaceuticals PLC Recent Developments and Future Plans
2.7 Teva Pharmaceutical Industries Ltd
2.7.1 Teva Pharmaceutical Industries Ltd Details
2.7.2 Teva Pharmaceutical Industries Ltd Major Business
2.7.3 Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Product and Solutions
2.7.4 Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.8 Viatris
2.8.1 Viatris Details
2.8.2 Viatris Major Business
2.8.3 Viatris Still’s Disease Treatment Product and Solutions
2.8.4 Viatris Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Viatris Recent Developments and Future Plans
2.9 Horizon Therapeutics plc
2.9.1 Horizon Therapeutics plc Details
2.9.2 Horizon Therapeutics plc Major Business
2.9.3 Horizon Therapeutics plc Still’s Disease Treatment Product and Solutions
2.9.4 Horizon Therapeutics plc Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Horizon Therapeutics plc Recent Developments and Future Plans
2.10 Sun Pharmaceutical Industries Ltd
2.10.1 Sun Pharmaceutical Industries Ltd Details
2.10.2 Sun Pharmaceutical Industries Ltd Major Business
2.10.3 Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Product and Solutions
2.10.4 Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.11 Zydus Cadila
2.11.1 Zydus Cadila Details
2.11.2 Zydus Cadila Major Business
2.11.3 Zydus Cadila Still’s Disease Treatment Product and Solutions
2.11.4 Zydus Cadila Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Zydus Cadila Recent Developments and Future Plans
2.12 Amneal Pharmaceuticals LLC
2.12.1 Amneal Pharmaceuticals LLC Details
2.12.2 Amneal Pharmaceuticals LLC Major Business
2.12.3 Amneal Pharmaceuticals LLC Still’s Disease Treatment Product and Solutions
2.12.4 Amneal Pharmaceuticals LLC Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Amneal Pharmaceuticals LLC Recent Developments and Future Plans
2.13 Dr Reddy’s Laboratories Ltd
2.13.1 Dr Reddy’s Laboratories Ltd Details
2.13.2 Dr Reddy’s Laboratories Ltd Major Business
2.13.3 Dr Reddy’s Laboratories Ltd Still’s Disease Treatment Product and Solutions
2.13.4 Dr Reddy’s Laboratories Ltd Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Dr Reddy’s Laboratories Ltd Recent Developments and Future Plans
2.14 Fresenius Kabi AG
2.14.1 Fresenius Kabi AG Details
2.14.2 Fresenius Kabi AG Major Business
2.14.3 Fresenius Kabi AG Still’s Disease Treatment Product and Solutions
2.14.4 Fresenius Kabi AG Still’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Fresenius Kabi AG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Still’s Disease Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Still’s Disease Treatment Players Market Share
3.2.2 Top 10 Still’s Disease Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Still’s Disease Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Still’s Disease Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Still’s Disease Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Still’s Disease Treatment Revenue Market Share by Application (2016-2021)
5.2 Still’s Disease Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Still’s Disease Treatment Revenue by Type (2016-2026)
6.2 North America Still’s Disease Treatment Revenue by Application (2016-2026)
6.3 North America Still’s Disease Treatment Market Size by Country
6.3.1 North America Still’s Disease Treatment Revenue by Country (2016-2026)
6.3.2 United States Still’s Disease Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Still’s Disease Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Still’s Disease Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Still’s Disease Treatment Revenue by Type (2016-2026)
7.2 Europe Still’s Disease Treatment Revenue by Application (2016-2026)
7.3 Europe Still’s Disease Treatment Market Size by Country
7.3.1 Europe Still’s Disease Treatment Revenue by Country (2016-2026)
7.3.2 Germany Still’s Disease Treatment Market Size and Forecast (2016-2026)
7.3.3 France Still’s Disease Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Still’s Disease Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Still’s Disease Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Still’s Disease Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Still’s Disease Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Still’s Disease Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Still’s Disease Treatment Market Size by Region
8.3.1 Asia-Pacific Still’s Disease Treatment Revenue by Region (2016-2026)
8.3.2 China Still’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Still’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Still’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.5 India Still’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Still’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Still’s Disease Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Still’s Disease Treatment Revenue by Type (2016-2026)
9.2 South America Still’s Disease Treatment Revenue by Application (2016-2026)
9.3 South America Still’s Disease Treatment Market Size by Country
9.3.1 South America Still’s Disease Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Still’s Disease Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Still’s Disease Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Still’s Disease Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Still’s Disease Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Still’s Disease Treatment Market Size by Country
10.3.1 Middle East & Africa Still’s Disease Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Still’s Disease Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Still’s Disease Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Still’s Disease Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Still’s Disease Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Still’s Disease Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Still’s Disease Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Still’s Disease Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Still’s Disease Treatment Revenue Market Share by Region (2021-2026)
Table 6. AB2 Bio Ltd Corporate Information, Head Office, and Major Competitors
Table 7. AB2 Bio Ltd Major Business
Table 8. AB2 Bio Ltd Still’s Disease Treatment Product and Solutions
Table 9. AB2 Bio Ltd Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 11. Novartis AG Major Business
Table 12. Novartis AG Still’s Disease Treatment Product and Solutions
Table 13. Novartis AG Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 15. F. Hoffmann-La Roche Ltd Major Business
Table 16. F. Hoffmann-La Roche Ltd Still’s Disease Treatment Product and Solutions
Table 17. F. Hoffmann-La Roche Ltd Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Swedish Orphan Biovitrum AB Corporate Information, Head Office, and Major Competitors
Table 19. Swedish Orphan Biovitrum AB Major Business
Table 20. Swedish Orphan Biovitrum AB Still’s Disease Treatment Product and Solutions
Table 21. Swedish Orphan Biovitrum AB Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Jubilant Corporate Information, Head Office, and Major Competitors
Table 23. Jubilant Major Business
Table 24. Jubilant Still’s Disease Treatment Product and Solutions
Table 25. Jubilant Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Hikma Pharmaceuticals PLC Corporate Information, Head Office, and Major Competitors
Table 27. Hikma Pharmaceuticals PLC Major Business
Table 28. Hikma Pharmaceuticals PLC Still’s Disease Treatment Product and Solutions
Table 29. Hikma Pharmaceuticals PLC Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Teva Pharmaceutical Industries Ltd Corporate Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Ltd Major Business
Table 32. Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Product and Solutions
Table 33. Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Viatris Corporate Information, Head Office, and Major Competitors
Table 35. Viatris Major Business
Table 36. Viatris Still’s Disease Treatment Product and Solutions
Table 37. Viatris Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Horizon Therapeutics plc Corporate Information, Head Office, and Major Competitors
Table 39. Horizon Therapeutics plc Major Business
Table 40. Horizon Therapeutics plc Still’s Disease Treatment Product and Solutions
Table 41. Horizon Therapeutics plc Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sun Pharmaceutical Industries Ltd Corporate Information, Head Office, and Major Competitors
Table 43. Sun Pharmaceutical Industries Ltd Major Business
Table 44. Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Product and Solutions
Table 45. Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 47. Zydus Cadila Major Business
Table 48. Zydus Cadila Still’s Disease Treatment Product and Solutions
Table 49. Zydus Cadila Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Amneal Pharmaceuticals LLC Corporate Information, Head Office, and Major Competitors
Table 51. Amneal Pharmaceuticals LLC Major Business
Table 52. Amneal Pharmaceuticals LLC Still’s Disease Treatment Product and Solutions
Table 53. Amneal Pharmaceuticals LLC Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Dr Reddy's Laboratories Ltd Corporate Information, Head Office, and Major Competitors
Table 55. Dr Reddy's Laboratories Ltd Major Business
Table 56. Dr Reddy's Laboratories Ltd Still’s Disease Treatment Product and Solutions
Table 57. Dr Reddy's Laboratories Ltd Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Fresenius Kabi AG Corporate Information, Head Office, and Major Competitors
Table 59. Fresenius Kabi AG Major Business
Table 60. Fresenius Kabi AG Still’s Disease Treatment Product and Solutions
Table 61. Fresenius Kabi AG Still’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Still’s Disease Treatment Revenue (USD Million) by Players (2019-2021)
Table 63. Global Still’s Disease Treatment Revenue Share by Players (2019-2021)
Table 64. Breakdown of Still’s Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Still’s Disease Treatment Players Head Office, Products and Services Provided
Table 66. Still’s Disease Treatment Mergers & Acquisitions in the Past Five Years
Table 67. Still’s Disease Treatment New Entrants and Expansion Plans
Table 68. Global Still’s Disease Treatment Revenue (USD Million) by Type (2016-2021)
Table 69. Global Still’s Disease Treatment Revenue Share by Type (2016-2021)
Table 70. Global Still’s Disease Treatment Revenue Forecast by Type (2021-2026)
Table 71. Global Still’s Disease Treatment Revenue by Application (2016-2021)
Table 72. Global Still’s Disease Treatment Revenue Forecast by Application (2021-2026)
Table 73. North America Still’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Still’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Still’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Still’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Still’s Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Still’s Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Still’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Still’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Still’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Still’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Still’s Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Still’s Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Still’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Still’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Still’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Still’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Still’s Disease Treatment Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Still’s Disease Treatment Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Still’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Still’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Still’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Still’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Still’s Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Still’s Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Still’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Still’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Still’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Still’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Still’s Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Still’s Disease Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Still’s Disease Treatment Picture
Figure 2. Global Still’s Disease Treatment Revenue Market Share by Type in 2020
Figure 3. Corticosteroids
Figure 4. Tocilizumab
Figure 5. Canakinumab
Figure 6. Anakinra
Figure 7. Others
Figure 8. Still’s Disease Treatment Revenue Market Share by Application in 2020
Figure 9. Retail Pharmacies Picture
Figure 10. Hospital Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Still’s Disease Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Still’s Disease Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Still’s Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 15. Global Still’s Disease Treatment Revenue Market Share by Region in 2020
Figure 16. North America Still’s Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Still’s Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Still’s Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Still’s Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Still’s Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Still’s Disease Treatment Market Drivers
Figure 22. Still’s Disease Treatment Market Restraints
Figure 23. Still’s Disease Treatment Market Trends
Figure 24. AB2 Bio Ltd Recent Developments and Future Plans
Figure 25. Novartis AG Recent Developments and Future Plans
Figure 26. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 27. Swedish Orphan Biovitrum AB Recent Developments and Future Plans
Figure 28. Jubilant Recent Developments and Future Plans
Figure 29. Hikma Pharmaceuticals PLC Recent Developments and Future Plans
Figure 30. Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
Figure 31. Viatris Recent Developments and Future Plans
Figure 32. Horizon Therapeutics plc Recent Developments and Future Plans
Figure 33. Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
Figure 34. Zydus Cadila Recent Developments and Future Plans
Figure 35. Amneal Pharmaceuticals LLC Recent Developments and Future Plans
Figure 36. Dr Reddy's Laboratories Ltd Recent Developments and Future Plans
Figure 37. Fresenius Kabi AG Recent Developments and Future Plans
Figure 38. Global Still’s Disease Treatment Revenue Share by Players in 2020
Figure 39. Still’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Still’s Disease Treatment Revenue Market Share in 2020
Figure 41. Global Top 10 Players Still’s Disease Treatment Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Still’s Disease Treatment Revenue Share by Type in 2020
Figure 44. Global Still’s Disease Treatment Market Share Forecast by Type (2021-2026)
Figure 45. Global Still’s Disease Treatment Revenue Share by Application in 2020
Figure 46. Global Still’s Disease Treatment Market Share Forecast by Application (2021-2026)
Figure 47. North America Still’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 48. North America Still’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 49. North America Still’s Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 50. United States Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Still’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 54. Europe Still’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 55. Europe Still’s Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 56. Germany Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Still’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Still’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Still’s Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 64. China Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Still’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 71. South America Still’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 72. South America Still’s Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Still’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Still’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Still’s Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Still’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のレイノー病治療市場 2021：企業別、地域別、種類・用途別 The Raynauds Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…- 世界の末期腎疾患治療市場 2021：企業別、地域別、種類・用途別 The End-Stage Kidney Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の先天性心疾患治療市場 2021：企業別、地域別、種類・用途別 The Congenital Heart Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の希少炎症性疾患治療市場 2021：企業別、地域別、種類・用途別 The Rare Inflammatory Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…